GlaxoSmithkline Consumer Healthcare standalone net profit rises 51.58% in the June 2018 quarter
08 - Aug - 2018 12:00 AM | 12 days ago
Net profit of GlaxoSmithkline Consumer Healthcare rose 51.58% to Rs 200.44 crore in the quarter ended June 2018 as against Rs 132.23 crore during the previous quarter ended June 2017. Sales rose 12.30% to Rs 1107.14 crore in the quarter ended June 2018 as against Rs 985.87 crore during the previous quarter ended June 2017.
GlaxoSmithkline Consumer Healthcare Ltd spurts 3.38%, rises for third straight session
03 - Aug - 2018 12:00 AM | 18 days ago
GlaxoSmithkline Consumer Healthcare Ltd rose for a third straight session today. The stock is quoting at Rs 6835, up 3.38% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.72% on the day, quoting at 11325.3. The Sensex is at 37429.52, up 0.71%. GlaxoSmithkline Consumer Healthcare Ltd has added around 6.05% in last one month.
Meanwhile, Nifty FMCG index of which GlaxoSmithkline Consumer Healthcare Ltd is a constituent, has added around 7.23% in last one month and is currently quoting at 31075.25, up 0.44% on the day. The volume in the stock stood at 13098 shares today, compared to the daily average of 15090 shares in last one month.
The PE of the stock is 39.71 based on TTM earnings ending March 18.
GlaxoSmithkline Consumer Healthcare announces appointment of change in nominee director
30 - Jun - 2018 12:00 AM | 51 days ago
GlaxoSmithkline Consumer Healthcare announced that Horlicks has nominated Patnam Dwarakanath as Nominee Director and Non-Executive Chairman of the Company with effect from 01 July 2018.
Zubair Ahmed has decided to step down as Nominee Director and Non-Executive Chairman and with effect from 30 June 2018.
